AstraZeneca PLC (AZN)
63.30
-1.74
(-2.68%)
USD |
NASDAQ |
Nov 15, 14:38
AstraZeneca Free Cash Flow (Quarterly): 2.417B for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.417B |
| March 31, 2024 | 881.00M |
| December 31, 2023 | 1.434B |
| September 30, 2023 | 2.235B |
| June 30, 2023 | 1.235B |
| March 31, 2023 | 1.663B |
| December 31, 2022 | 1.844B |
| September 30, 2022 | 1.819B |
| June 30, 2022 | 705.00M |
| March 31, 2022 | 2.869B |
| December 31, 2021 | 700.00M |
| September 30, 2021 | 1.059B |
| June 30, 2021 | 539.00M |
| March 31, 2021 | 1.465B |
| December 31, 2020 | 1.25B |
| September 30, 2020 | 1.117B |
| June 30, 2020 | 63.00M |
| March 31, 2020 | -237.00M |
| December 31, 2019 | 990.00M |
| September 30, 2019 | 762.00M |
| June 30, 2019 | -96.00M |
| March 31, 2019 | -1.147B |
| December 31, 2018 | 1.815B |
| September 30, 2018 | 200.00M |
| June 30, 2018 | -294.00M |
| Date | Value |
|---|---|
| March 31, 2018 | -474.00M |
| December 31, 2017 | 446.00M |
| September 30, 2017 | 1.89B |
| June 30, 2017 | -81.00M |
| March 31, 2017 | -297.00M |
| December 31, 2016 | 1.319B |
| September 30, 2016 | 445.00M |
| June 30, 2016 | -820.00M |
| March 31, 2016 | 887.00M |
| December 31, 2015 | 36.00M |
| September 30, 2015 | 1.211B |
| June 30, 2015 | 436.00M |
| March 31, 2015 | -1.147B |
| December 31, 2014 | 1.373B |
| September 30, 2014 | 1.535B |
| June 30, 2014 | 939.00M |
| March 31, 2014 | 459.00M |
| December 31, 2013 | 1.692B |
| September 30, 2013 | 644.00M |
| June 30, 2013 | 1.222B |
| March 31, 2013 | 1.784B |
| December 31, 2012 | 2.284B |
| September 30, 2012 | -2.263B |
| June 30, 2012 | 970.00M |
| March 31, 2012 | 1.338B |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-237.00M
Minimum
Mar 2020
2.869B
Maximum
Mar 2022
1.266B
Average
1.235B
Median
Jun 2023
Free Cash Flow (Quarterly) Benchmarks
| GSK PLC | 1.749B |
| Amgen Inc | 3.314B |
| Johnson & Johnson | 5.714B |
| Eli Lilly and Co | -458.90M |
| Sanofi SA | -- |